## Abstract To investigate whether __Helicobacter pylori (__HP) infection affects the clinical response to levodopa and whether its eradication could improve motor fluctuation in patients with Parkinson's disease (PD). Using the [^13^C] urea breath test, we monitored HP infection in 65 patients wit
Pharmacokinetics of levodopa and 3-omd in patients with Parkinson's disease and motor fluctuations infected with Helicobacter pylori
✍ Scribed by Narożańska, E.; Białecka, M.; Adamiak-Giera, U.; Gawrońska-Szklarz, B.; Sołtan, W.; Schinwelski, M.; Robowski, P.; Madaliński, M.; Sławek, J.
- Book ID
- 122096260
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 69 KB
- Volume
- 333
- Category
- Article
- ISSN
- 0022-510X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The objective of this study was to evaluate the efficacy, safety, and tolerability of istradefylline 20 mg once daily versus placebo as an adjunct to levodopa in subjects with Parkinson's disease (PD) who have motor fluctuations. Istradefylline (KW‐6002) is an adenosine A~2A~ receptor a
## Abstract The cause of motor fluctuations occurring during constant‐rate levodopa infusions is unknown. We examined whether known pharmacokinetic factors could explain the fluctuations and looked for clues to pharmacodynamic causes. Eleven subjects with stage III–V Parkinson's disease (PD) and a
## Abstract Although clinical rating scales and simple timed tests of motor function are widely used to assess motor response to therapy, gait analysis may provide an alternative measure of this response. We studied 15 patients with PD complicated by motor fluctuations, first to determine changes i